No posts to display

RECENT POST

Novartis spends $2.1B to snap up targeted radiotherapy drug for prostate...

Swiss drugmaker Novartis made a big investment in radiopharmaceuticals with the Thursday announcement that it will acquire a US firm with an oncology...